Insight Molecular Diagnostics Financial Overview
Insight Molecular Diagnostics's market cap is currently $149.49M. The company's EPS TTM is $-0.2; its P/E ratio is -1.77; Insight Molecular Diagnostics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
